Vineet Laboratories Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
VINEETLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.2 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Vineet Laboratories reported Q1 FY26 revenue from operations of ₹744.18 lakhs, down sharply from ₹2,386.16 lakhs in the same quarter last year — a YoY decline of roughly 69%. The company posted a net loss of ₹86.61 lakhs for the quarter, compared to a loss of ₹213.07 lakhs in Q1 FY25, while the full year FY25 had ended with a much larger loss of ₹2,019.10 lakhs. Total expenses for the quarter were ₹836.14 lakhs against total income of ₹745.98 lakhs, keeping the business in the red. Statutory auditors NSVR & Associates LLP issued an unqualified limited review report with no qualifications or emphasis of matter. The balance sheet shows total assets of ₹8,854.38 lakhs, equity of ₹1,382 lakhs, and total borrowings of roughly ₹3,951 lakhs, indicating a high leverage profile.
Sharp revenue contraction and continued quarterly losses point to ongoing operational stress, which is likely to weigh negatively on the stock. The high debt relative to thin equity also raises concerns about financial stability, even though the auditor's report is clean.